The ethics of early stopping rules: who is protecting whom?
Cannistra
Stephen A
SA
Program in Gynecologic Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic / Q000941:ethics*; D003657:Decision Making; D023381:Endpoint Determination; D004992:Ethics, Medical; D005260:Female; D006801:Humans; D007258:Informed Consent; D009364:Neoplasm Recurrence, Local; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010344:Patient Advocacy; D018579:Patient Selection; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic / Q000941:ethics*; D012107:Research Design; D016019:Survival Analysis